ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
April 24, 2026
April 24, 2026
Categories
  • From the Co-Chairs

From the Co-Chairs, April 2026

A preview of the upcoming Spring Group Meeting, a recap of AACR 2026, and an update on the current state of the NCI's cancer research efforts
Do you like it?
0 Read more
April 24, 2026
April 24, 2026
Categories
  • Active Clinical Trials

Coming Soon: EA1242/RxFINE-Low for Patients With High Anatomic Risk, Low Genomic Risk ER+/HER2- Breast Cancer

This phase 3 clinical trial is comparing aromatase inhibitors and ribociclib, with and without chemotherapy, to prevent recurrence
Do you like it?
0 Read more
April 24, 2026
Doctor examining patient's neck
April 24, 2026
Categories
  • Active Clinical Trials

Trial Spotlight: Dan Zandberg Provides an Update on the EA3191 Study for Patients With Head and Neck Cancer

This phase 2 trial is evaluating pembrolizumab immunotherapy after surgery in patients with recurrent or second primary head and neck cancer with high-risk features
Do you like it?
0 Read more
April 24, 2026
Research definition
April 24, 2026
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research Round-Up

The latest clinical trial findings in breast cancer, cancer control and survivorship, health equity, leukemia, melanoma, and NCI-MATCH
Do you like it?
0 Read more
April 24, 2026
News in Brief image
April 24, 2026
Categories
  • News in Brief

News in Brief, April 2026

Timely information about research presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc